Article
Effect of a COVID-19-Heterologous Vaccination Schedule on Haemostasis: A Subanalysis of the Phase 2, Multicentre, Randomised, Controlled CombiVacS Study
2022-03-01
Abstract excerpt
Background: Several cases of unusual thrombotic events and thrombocytopenia have occurred after vaccination with recombinant adenoviral vectors encoding the spike protein antigen of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We aimed to elucidate the impact of a COVID-19 heterologous vaccination schedule including priming with an adenovirus vaccine on haemostasis and coagulation profile.<br><br>...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 31fe7187-dcc8-5a41-a51b-82a89d3b4f9c
- DOI
- 10.2139/ssrn.4046663
